Year of Award:
Molecular & Cellular Analysis Technologies
JEFFREY, STEFANIE S.
Other PI or Project Leader:
We are motivated by the view that development of a reliable and robust technology for efficient detection, characterization, and direct assay of minimal residual disease (MRD), including circulating tumor cells (CTCs) from blood and disseminated tumor cel